|
1
|
Curtin JC: Novel drug discovery
opportunities for colorectal cancer. Expert Opin Drug Discov.
8:1153–1164. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lei T, Chen WQ, Zhang SW, Lei TH, Ying Q,
He ZY and Wang XH: Prevalence trend of colorectal cancer in 10
cities and counties in China from 1988 to 2002. Zhonghua Zhong Liu
Za Zhi. 31:428–433. 2009.(In Chinese). PubMed/NCBI
|
|
3
|
Li HL, Gao YT, Zheng Y, Zhang W, Gao LF,
Xu B and Xiang YB: Incidence trends of colorectal cancer in urban
Shanghai, 1973-2005. Zhonghua Yu Fang Yi Xue Za Zhi. 43:875–879.
2009.(In Chinese). PubMed/NCBI
|
|
4
|
Bertrand FE, Angus CW, Partis WJ and
Sigounas G: Developmental pathways in colon cancer: crosstalk
between WNT, BMP, Hedgehog and Notch. Cell Cycle. 11:4344–4351.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu WK, Wang XJ, Cheng AS, Luo MX, Ng SS,
To KF, Chan FK, Cho CH, Sung JJ and Yu J: Dysregulation and
crosstalk of cellular signaling pathways in colon carcinogenesis.
Crit Rev Oncol Hematol. 86:251–277. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saif MW and Chu E: Biology of colorectal
cancer. Cancer J. 16:196–201. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mishra L, Banker T, Murray J, Byers S,
Thenappan A, He AR, Shetty K, Johnson L and Reddy EP: Liver stem
cells and hepatocellular carcinoma. Hepatology. 49:318–329. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ischenko I, Seeliger H, Schaffer M, Jauch
KW and Bruns CJ: Cancer stem cells: how can we target them? Curr
Med Chem. 15:3171–3184. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang G, Brennan C, Rook M, Wolfe JL, Leo
C, Chin L, Pan H, Liu WH, Price B and Makrigiorgos GM: Balanced-PCR
amplification allows unbiased identification of genomic copy
changes in minute cell and tissue samples. Nucleic Acids Res.
32:e762004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pope JL, Ahmad R, Bhat AA, Washington MK,
Singh AB and Dhawan P: Claudin-1 overexpression in intestinal
epithelial cells enhances susceptibility to adenamatous polyposis
coli-mediated colon tumorigenesis. Mol Cancer. 13:1672014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Umar S: Enteric pathogens and cellular
transformation: bridging the gaps. Oncotarget. 5:6573–6575. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gopalakrishnan N, Saravanakumar M,
Madankumar P, Thiyagu M and Devaraj H: Colocalization of β-catenin
with Notch intracellular domain in colon cancer: a possible role of
Notch1 signaling in activation of CyclinD1-mediated cell
proliferation. Mol Cell Biochem. 396:281–293. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kwon C, Cheng P, King IN, Andersen P,
Shenje L, Nigam V and Srivastava D: Notch post-translationally
regulates β-catenin protein in stem and progenitor cells. Nat Cell
Biol. 13:1244–1251. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bordonaro M, Tewari S, Atamna W and
Lazarova DL: The Notch ligand Delta-like 1 integrates inputs from
TGFbeta/Activin and Wnt pathways. Exp Cell Res. 317:1368–1381.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu J, Wang J, Shi Z, Franklin JL, Deane
NG, Coffey RJ, Beauchamp RD and Zhang B: Deciphering genomic
alterations in colorectal cancer through transcriptional
subtype-based network analysis. PLoS One. 8:e792822013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Prasetyanti PR, Zimberlin CD, Bots M,
Vermeulen L, Fde S Melo and Medema JP: Regulation of stem cell
self-renewal and differentiation by Wnt and Notch are conserved
throughout the adenoma-carcinoma sequence in the colon. Mol Cancer.
12:1262013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Reedijk M, Odorcic S, Zhang H, Chetty R,
Tennert C, Dickson BC, Lockwood G, Gallinger S and Egan SE:
Activation of Notch signaling in human colon adenocarcinoma. Int J
Oncol. 33:1223–1229. 2008.PubMed/NCBI
|
|
19
|
Katoh M and Katoh M: Notch ligand, JAG1,
is evolutionarily conserved target of canonical WNT signaling
pathway in progenitor cells. Int J Mol Med. 17:681–685.
2006.PubMed/NCBI
|
|
20
|
Korkaya H and Wicha MS: Selective
targeting of cancer stem cells: a new concept in cancer
therapeutics. BioDrugs. 21:299–310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Karamboulas C and Ailles L: Developmental
signaling pathways in cancer stem cells of solid tumors. Biochim
Biophys Acta. 1830:2481–2495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Roy S and Majumdar AP: Signaling in colon
cancer stem cells. J Mol Signal. 7:112012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pandurangan AK and Esa NM: Dietary
non-nutritive factors in targeting of regulatory molecules in
colorectal cancer: an update. Asian Pac J Cancer Prev.
14:5543–5552. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Singh BN, Shankar S and Srivastava RK:
Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms,
perspectives and clinical applications. Biochem Pharmacol.
82:1807–1821. 2011. View Article : Google Scholar : PubMed/NCBI
|
